Slow-type arrhythmia
Conditions
Interventions
Exploratory Clinical Study (Phase 1):None
Verification Clinical Study (Phase 2):None
Sponsors
Zhongda Hospital Affiliated to Southeast University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. age >=18 years old 2. Patients who met the indications for pacemaker implantation according to current guidelines and were preparing for the first transvenous implantation of a permanent pacemaker in the chest 3. It was consistent with the application of intracardiac echocardiography. 4. Patients provided written informed consent and were expected to complete all scheduled follow-up visits and examinations as required by the protocol
Exclusion criteria
Exclusion criteria: 1. Other active or discarded cardiac implants were present in patients 2. Patients had undergone cardiac-related surgery (including ventriculotomy, atriotomy, atrial septal occlusion, or left atrial appendage occlusion) or valve-related surgery 3. Patients had known contraindications, including sepsis, severe coagulation abnormalities, intracardiac thrombosis, severe angina or heart failure, deep vein thrombosis, severe peripheral vascular disease, hemodynamic instability, or a history of malignancy 4. Women who plan to become pregnant, pregnant, or breastfeeding 5. Participating in other interventional clinical investigators 6. The investigator judged that the subjects had poor compliance, were unable to complete the study as required, and were otherwise not suitable for participating in this clinical study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pacing threshold;perceived amplitude;pacing impedance; | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of adverse events and serious adverse events related to intracardiac ultrasound imaging and/or pacing system implantation; | — |
Countries
China
Contacts
Public ContactLong Chen
Zhongda Hospital Affiliated to Southeast University
Outcome results
None listed